CRGX•benzinga•
CARGO Therapeutics Suspends CRG-023 & Allogeneic Platform, Initiates 90% Workforce Reduction; Anup Radhakrishnan Named Interim CEO To Explore Reverse Merger; $368.1M Cash Reserves As Of Year-End 2024
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 18, 2025 by benzinga